Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,429,580 papers from all fields of science
Search
Sign In
Create Free Account
nacartocin
Known as:
2-(4-Et-Phe)-deamino-6-carbaoxytocin
, oxytocin, (4-Et-Phe)(2)-deamino-6-carba-
, oxytocin, (4-ethylphenylalanine)(2)-deamino-6-carba-
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Oxytocin
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Natriuretic properties of [2-p-ethylphenylalanine] deamino-6-carba-oxytocin (Nacartocin) in cats.
J. Škopková
,
T. Barth
,
P. Hrbas
,
K. Jošt
,
M. Lebel
Experimental and clinical endocrinology
2009
Corpus ID: 10382116
Nacartocin, a synthetic analogue of oxytocin, [2-L-p-phenylalanine]deamino-6-carba-oxytocin has a specific natriuretic effect in…
Expand
1986
1986
The natriuretic effect of 1-24 ACTH in rats: a comparison with the natriuretic oxytocin analogue nacartocin.
A. Machová
,
V. Schreiber
Physiologia Bohemoslovaca
1986
Corpus ID: 8445239
A slight but significant natriuretic action of 1-24 ACTH was confirmed both in trained conscious nonhydrated rats and in…
Expand
1985
1985
The effects of nacartocin and oxytocin on the cardiovascular system of rabbits in vivo.
V. Geršl
,
K. Hajzlerová
,
V. Troppová
Sbornik vedeckych praci Lekarske fakulty Karlovy…
1985
Corpus ID: 45130179
1984
1984
Nacartocin--analogue of oxytocin with enhanced natriuretic properties: natriuretic and hemodynamic characteristics.
P. Hrbas
,
J. Škopková
,
J. Zicha
,
T. Barth
,
M. Lebl
,
K. Jošt
Endocrinologia experimentalis
1984
Corpus ID: 22021513
Nacartocin, [2-p-ethylphenylalanine]deamino-6-carba-oxytocin, is almost three times more potent than oxytocin as a natriuretic…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE